ISIN | IE00BWBXM617 |
---|---|
Valor Number | 28805622 |
Bloomberg Global ID | |
Fund Name | SPDR S&P U.S. Health Care Select Sector UCITS ETF USD |
Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
Fund Provider | State Street Investment Management |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of large sized U. S. health care companies in the S&P 500 Index. |
Peculiarities |
Current Price * | 41.08 USD | 14.08.2025 |
---|---|---|
Previous Price * | 40.88 USD | 13.08.2025 |
52 Week High * | 47.56 USD | 02.09.2024 |
52 Week Low * | 39.37 USD | 14.05.2025 |
NAV * | 41.08 USD | 14.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 314,025,499 | |
Unit/Share Assets *** | 314,025,498 | |
Trading Information SIX |
YTD Performance | -1.98% |
31.12.2024 - 14.08.2025
31.12.2024 14.08.2025 |
---|---|---|
YTD Performance (in CHF) | -13.04% |
31.12.2024 - 14.08.2025
31.12.2024 14.08.2025 |
1 month | -0.85% |
14.07.2025 - 14.08.2025
14.07.2025 14.08.2025 |
3 months | +4.34% |
14.05.2025 - 14.08.2025
14.05.2025 14.08.2025 |
6 months | -6.88% |
14.02.2025 - 14.08.2025
14.02.2025 14.08.2025 |
1 year | -10.59% |
14.08.2024 - 14.08.2025
14.08.2024 14.08.2025 |
2 years | +1.10% |
14.08.2023 - 14.08.2025
14.08.2023 14.08.2025 |
3 years | +3.78% |
15.08.2022 - 14.08.2025
15.08.2022 14.08.2025 |
5 years | +33.72% |
14.08.2020 - 14.08.2025
14.08.2020 14.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 12.28% | |
---|---|---|
Johnson & Johnson | 8.36% | |
AbbVie Inc | 7.04% | |
UnitedHealth Group Inc | 4.78% | |
Abbott Laboratories | 4.63% | |
Merck & Co Inc | 4.14% | |
Thermo Fisher Scientific Inc | 3.72% | |
Intuitive Surgical Inc | 3.64% | |
Amgen Inc | 3.35% | |
Boston Scientific Corp | 3.27% | |
Last data update | 31.07.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.15% |
Ongoing Charges *** | 0.15% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |